AstraZeneca has partnered with Taiwan’s National Research Program for Biopharmaceuticals (NRPB) in order to support academic research proposals using 'open innovation' as a catalyst for accelerating drug discovery. The project will ...
Biopharmaceutical firm Berg and the Icahn School of Medicine at Mount Sinai have entered into a pharmaceutical and diagnostic R&D deal to leverage the power of multi-omic biology and data analytics. The deal is intended to secure new ...
US-based biotechnology company X-Chem and UK-based pharmaceutical company AstraZeneca have entered into an expanded global drug discovery collaboration that covers all of AstraZeneca’s therapeutic areas and multiple target classes. ...
Tags: Drug, pharmaceutical
Golden Biotechnology Corp. from Taiwan recently held a press conference in Beijing, launching Antroquinonol. Golden Biotechnology is a local leader in the Antrodia camphorate field, having put USD 100 million in research and development ...
Tags: Biotechnology, Health, Medicine
Biopharmaceutical company Trigemina will deliver clinical data on its drug candidate TI-001 for the treatment of chronic migraine at the ongoing 7th Annual Pain Therapeutics Summit East in Boston, Massachusetts. The presentation will ...
Tags: Migraine Drug, Medicine
Plexcera Therapeutics has received approval from Mount Sinai Innovation Partners (MSIP), part of the Icahn School of Medicine, to develop recombinant human acid ceramidase (rhAC) for treatment of diseases caused by genetic or ...
Tags: Plexcera, Cystic Fibrosis
Sweden-based medical technology company Aerocrine has launched the NIOX VERO device, designed to measure the airway inflammation, such as asthma. Aerocrine and Panasonic Healthcare have jointly developed the new fully portable hand-held ...
Swedish biotechnology firm Karo Bio (KARO) has achieved its first milestone in a research agreement with Pfizer for the development of drugs for treatment of autoimmune diseases. The achievement of milestone in the RORgamma project ...
Japanese firms Ono Pharma and Bristol-Myers KK (BMKK) have rolled out the rheumatoid arthritis drug, Orencia Subcutaneous Injection 125mg Syringe 1ml, in Japan. Orencia SC, whose generic name is abatacept, restrains the discharge of ...
Neutra (NTRR), a provider of all-natural wellness solutions, has initiated the development activities for a new oral delivery system for nutraceuticals including medical marijuana. Dr Richard Kaufman has been hired by Neutra to oversee ...
The Drexel University School of Biomedical Engineering, Science and Health Systems in collaboration with the College of Medicine in the US has developed a small ultrasound device that could speed up the process of healing chronic wounds. ...
Tags: Chronic Wounds, Ultrasound Device
Pharmaceutical research and development company Serina Therapeutics has partnered with the Scripps Research Institute to jointly develop polymer-antibody drug conjugates (Polymer-ADCs). Terms and financial details of the deal have not ...
Tags: Polymer-Antibody Drug, Medicine
Pfizer is planning for internal classification of its commercial operations into three business segments, which will include developed and emerging markets, in an effort to deliver value to consumers and patients. The three business ...
Tags: Pfizer, Commercial Businesses
Chinese have been using the green and leafy andrographis paniculata to treat inflammation, fever and pain for decades, with its cultivation dating back to at least the 1950s in the southern province of Guangdong. The plant, better known ...
Tags: Chinese Medicine, Medicine
Biotechnology company Momenta Pharmaceuticals has announced the issuance of a patent from the US Patent and Trademark Office to The Rockefeller University for sialylation technology. The patent expires in 2028 and covers methods of ...
Tags: Momenta, US Patent, Sialylation Technology